Request Deal Involvement

WuXi Biologics completed the acquisition of a Wuppertal facility from Bayer for £101m.

Identify your role

Select the side you represented in this transaction, and provide your current job title.

Service Providers

Redeker Sellner & Dahs

legal advisors

Redeker Sellner & Dahs

Commerzbank

financial advisors

Commerzbank

Heuking Kuhn Luer Wojtek

legal advisors

Heuking Kuhn Luer Wojtek

or

Principals

BAYER (WUPPERTAL PHARMACEUTICALS DIVISION)

target

BAYER (WUPPERTAL PHARMACEUTICALS DIVISION)

BAYER AG

vendor

BAYER AG

WUXI BIOLOGICS

bidder

WUXI BIOLOGICS

Principals or Service Provider not listed?Add missing Service Provider or Principal

Enter your Job Title on this deal

This title will appear on your profile next to this deal involvement.


To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:

All rights reserved. Copyright © 2025 Datasite

MergerLinks - Request Credit - WuXi Biologics completed the acquisition of a Wuppertal facility from Bayer for £101m.